Cision PR Newswire

OncoC4 Announces NMPA Acceptance of Two IND Applications for Cesalatamig Combination Studies with ADCs and Pan-RAS Inhibitors

— New Studies Expand Cesalatamig into Biomarker-driven Precision Immuno-oncology Strategies — Cesalatamig is Also Being Evaluated in Ongoing Phase 2 Studies in the...

Julia Gillard joins Hakluyt’s International Advisory Board

LONDON, Oct. 19, 2026 /PRNewswire/ -- Hakluyt, the global strategic advisory firm for businesses...

2026 Canton Fair Design Award Winners Showcase China’s Innovation Strength

GUANGZHOU, China, Oct. 19, 2026 /PRNewswire/ -- As the 140th Canton Fair opens, the winners...

Transforming Lives with TAVI: A Milestone in Aortic Stenosis Treatment

MANILA, Philippines, April 16, 2025 /PRNewswire/ -- The Philippine Heart Center has reached a significant milestone by successfully performing six Transcatheter Aortic Valve Implantation...

Autoliv Receives 2025 Automotive News PACE Pilot Recognition

STOCKHOLM, April 16, 2025 /PRNewswire/ -- Autoliv, Inc. (NYSE: ALV) (SSE: ALIVsdb), was named a 2025 Automotive News PACE Pilot Innovation to Watch at...

Autoliv: Financial Report January – March 2025

STOCKHOLM, April 16, 2025 /PRNewswire/ -- (NYSE: ALV) (SSE: ALIV.sdb) Q1 2025: Good sales and execution of cost reduction programs Financial highlights...